Viewing data from:

CALCIUM ACETATE

ANDA

CALCIUM ACETATE | A203135 | INVAGEN PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Roxane Laboratories, Inc. v. Camber Pharmaceuticals, Inc. et al 2:2014cv04042 1 patentANDA 77728, 203135calcium acetate	D.N.J.	2014-06-25	Terminated 2018-07-02	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain6 active DMFs1 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

NIACET BVCALCIUM ACETATE

DMF 189972005

VASA PHARMACHEM PVT LTDCALCIUM ACETATE

DMF 225502009

SUVEN LIFE SCIENCES LTDCALCIUM ACETATE USP

DMF 227522009

MACCO ORGANIQUES INCCALCIUM ACETATE

DMF 291662015

GLOBAL CALCIUM PRIVATE LTDCALCIUM ACETATE USP

DMF 356342021

LUOYANG LONGMEN PHARMACEUTICAL CO LTDCALCIUM ACETATE

DMF 426662025

FORMOSA LABORATORIES INCInactiveCALCIUM ACETATE USP

DMF 237352010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 667MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Feb 7, 2013

No patent or exclusivity listings for this strength.